Medine.co.uk

Paxcutol 2.5875% W/V Shampoo

Revised: 08 September 2009

AN: 02108/2008

SUMMARY OF PRODUCT CHARACTERISTICS


1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Paxcutol 2.5875 % w/v Shampoo


2. QUALITATIVE AND QUANTITATIVE COMPOSITION


Active substance(s) % w/v

Benzoyl peroxide…………………………………2.5875 % w/v


For full list of excipients, see section 6.1


3. PHARMACEUTICAL FORM

Shampoo.

Whitish, viscous, homogeneous shampoo


4. CLINICAL PARTICULARS


Target Species


Dogs


Indications for use, specifying the target species


For the treatment of canine skin disease where bacterial infection and/or seborrhoea are involved.


Contra-indications


None


Special warnings for each target species


Avoid contact with the eyes and mucous membranes.


Special precautions for use


i. Special precautions for use in animals


For external use only.

Avoid contact with dog’s eyes and mucous membranes during treatment.


ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals


Impervious gloves should be worn at all times when applying the product.

Irritant: irritation to skin and eyes.

Avoid contact with the eyes and mucous membranes.

Remove any splashes with plenty of water and in case of contact with eyes, seek medical advice.

When using the product, do not eat, drink or smoke.

Wash hands after use.


Other precautions


Old clothes should be worn when applying the shampoo as contact may damage some fabrics.


Adverse reactions (frequency and seriousness)


Dogs may show signs of sensitivity to the shampoo.

Should irritation or skin inflammation occur, treatment should be discontinued.


Use during pregnancy, lactation or lay


The product can be used during pregnancy and lactation.


Interaction with other medicinal products and other forms of interaction


None Known


Amounts to be administrated and administration route


Shake container before use. Before applying the shampoo, thoroughly wet the coat. The shampoo is to be massaged into the coat in sufficient quantity until a good lather is achieved and then rinsed. The shampoo is applied a second time and left for 10 minutes, followed by rinsing with warm water. In cases where lesions are not widespread, the product may be applied locally. Initially, a once- daily treatment is recommended with use on its own or concurrently with specific therapy. As the skin condition responds to therapy, the interval may be extended to a frequency of once monthly. The suggested volume of shampoo is:


Avoid contact with the eyes and mucous membranes.

Overdose (symptoms, emergency procedures, antidotes), if necessary


Not applicable


Withdrawal period(s)


Not applicable


PHARMACOLOGICAOL PROPERTIES


ATC vet: QD11AX10


Paxcutol Shampoo is an antibacterial and keratolytic preparation for use on dogs. It contains as active ingredient 2.5875 % w/v benzoyl peroxide, and oxidating substance.


5.1 Pharmacodynamic properties


Benzoyl peroxide, when applied on the skin, decomposes releasing benzoyl peroxy radicals and nascent oxygen, after interacting with biological substances, thermal variation and ultra-violet exposure. When the free radicals are formed, reactions such as interactions with (-OH) hydroxyl and (-SH) sulfhydryl groups, double bonds and aromatic compounds occur. The results of these interactions disrupt the membranes of bacterial cells, altering permeability of the membrane and, subsequently, the function of the cell. It is therefore indicated for the treatment of topical ailments involving bacterial infections. Additionally, benzoyl peroxide reduces the activity of seborrheic glands, contributing to resolving seborrhoeic conditions.

5.2 Pharmacokinetic properties

Benzoyl peroxide reacts rapidly with cysteine, an integral amino acid contained in keratin. In reacting with cysteine, benzoyl peroxide is rapidly reduced to benzoic acid and various benzoate salts which do not penetrate the skin and are biologically harmless. The interaction of benzoyl peroxide with skin is usually of no untoward consequence.


PHARMACEUTICAL PARTICULARS


List of excipients


Propylene Glycol

Coconut Diethanolamide

Sodium Lauryl Ether Sulphate (28% solution)

Magnesium-Aluminium Silicate

Citric Acid Monohydrate

Water Purified


Incompatibilities


None Known

Shelf Life


Shelf life of the veterinary medicinal product as packaged for sale: 18 months


Special precautions for storage


Do not store above 25°C.

Protect from light.


Nature and composition if immediate packaging

125 ml, 150 ml, 200 ml, 1 L white opaque high-density polyethylene bottle with white high density polyethylene and polypropylene cap (screw – fit).

Not all pack sizes maybe marketed.


Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products


Any unused product or waste material should be disposed of in accordance with national requirements.


MARKETING AUTHORISATION HOLDER


VIRBAC S.A.,

1ère avenue – 2065 m – L.I.D.,

06516 Carros Cedex

France


8. MARKETING AUTHORISATION NUMBER


Vm 05653/4018


DATE OF FIRST AUTHORISATION


20/05/1988


DATE OF REVISION OF THE TEXT


September 2009